BioCentury
ARTICLE | Clinical News

Sepracor, HMR regulatory update

July 29, 1996 7:00 AM UTC

HMR's Allegra terfenadine carboxylate, a non-sedating antihistamine, received FDA marketing approval. HMR licensed SEPR's U.S. patent rights to the compound in June 1993 (see Noteworthy, Part 1). ...